Clinical Transplantation of Initially Rejected Donor Lungs After Reconditioning Ex Vivo

Annals of Thoracic Surgery

Volumn 87, Issue 1, 2009, Pages 255-260

  Ingemansson, Richard ^a   Eyjolfsson, Atli ^a   Mared, Lena ^a   Pierre, Leif ^a   Algotsson, Lars ^a   Ekmehag, Björn ^a   Gustafsson, Ronny ^a   Johnsson, Per ^a   Koul, Bansi ^a   Lindstedt, Sandra ^a   Lührs, Carsten ^a   Sjöberg, Trygve ^a   Steen, Stig ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; EXTRACORPOREAL OXYGENATION; FEMALE; GRAFT SURVIVAL; HUMAN; LUNG GRAFT REJECTION; LUNG PARENCHYMA; LUNG TRANSPLANTATION; MALE; ORGAN DONOR; PRIORITY JOURNAL; SEPSIS; SURGICAL MORTALITY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; COHORT STUDIES; DONOR SELECTION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN PRESERVATION; REPERFUSION; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TISSUE AND ORGAN PROCUREMENT;

EID: 57649237744     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.09.049     Document Type: Article

References (12)

1. Punch J.D., Hayes D.H., LaPorte F.B., McBride V., and Seely M.S. Organ donation and utilization in the United States, 1996-2005. Am J Transpl 7 (2007) 1327-1338
2. Trulock E.P., Edwards L.B., Taylor D.O., Boucek M.M., Keck B.M., and Hertz M.I. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report - 2004. J Heart Lung Transplant 23 (2004) 804-815
3. Maurer J.R., Frost A.E., Estenne M., Higenbottam T., and Glanville A.R. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, The European Respiratory Society. J Heart Lung Transplant 17 (1998) 703-709
4. Steen S., Sjöberg T., Pierre L., Liao Q., Eriksson L., and Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 357 (2001) 825-829
5. Steen S., Liao Q., Wierup P., Bolys R., Pierre L., and Sjöberg T. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg 76 (2003) 244-252
6. Wierup P., Haraldsson Å., Nilsson F., et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg 81 (2006) 460-466
7. Steen S., Ingemansson R., Eriksson L., et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 83 (2007) 2191-2195
8. Steen S., Liao Q., Pierre L., Paskevicius A., and Sjöberg T. Evaluation of LUCAS, a new device for automatic mechanical compression and active decompression resuscitation. Resuscitation 55 (2002) 285-299
9. Steen S., Sjöberg T., Olsson P., and Young M. Treatment of out-of-hospital cardiac arrest with LUCAS, a new device for automatic mechanical compression and active decompression resuscitation. Resuscitation 67 (2005) 25-30
10. Steen S., Kimblad P.O., Sjöberg T., Lindberg L., Ingemansson R., and Massa G. Safe lung preservation for twenty-four hours with Perfadex. Ann Thorac Surg 57 (1994) 450-457
11. Ingemansson R., Massa G., Pandita R., Sjöberg T., and Steen S. Perfadex is superior to Euro-Collins solution regarding 24-hour preservation of vascular function. Ann Thorac Surg 60 (1995) 1210-1214
12. Steen S. Improvement in lung preservation. Prog Appl Microcirc 22 (1996) 50-60